Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature

2012 
Purpose A 128-gene signature has been proposed to predict outcome in patients with stages II and III colorectal cancers. In the present study, we aimed to reproduce and validate the 128-gene signature in external and independent material.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    31
    References
    21
    Citations
    NaN
    KQI
    []